This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schnabel, R. Articles by Blankenberg, S. Search for Related Content PubMed PubMed Citation Articles by Schnabel, R. Articles by Blankenberg, S. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB (L)-ARGININE NITRIC OXIDE Related Collections Pathophysiology Risk Factors Endothelium/vascular type/nitric oxide

(Circulation. 2007;116:1338-1340.)
© 2007 American Heart Association, Inc.

Editorial

Oxidative Stress in Cardiovascular Disease

Successful Translation From Bench to Bedside?

Renate Schnabel, MD; Stefan Blankenberg, MD

From the Department of Medicine II, Johannes Gutenberg-University Mainz, Mainz, Germany.

Correspondence to Dr Stefan Blankenberg, Johannes Gutenberg-University Mainz, Department of Medicine II, Langenbeckstrasse 1, 55131 Mainz, Germany. E-mail blankenberg@2-med.klinik.uni-mainz.de

Key Words: Editorials • antioxidants • atherosclerosis • endothelium

An extract of the first 250 words of the full text is provided, because this article has no abstract.

	Introduction

 
Over the last decades, sound evidence has been generated that oxidative stress is one of the most potent inductors of endothelial dysfunction and is involved at all stages of atherosclerotic plaque evolution.^1,2 Experimental and animal models provide a clear association between the amount of oxidative challenge and reversible vascular dysfunction that can be observed before permanent alterations of the vessel wall occur.

Article p 1367

Important for cardiovascular biology is the consumption of nitric oxide (NO) by reactive oxygen species. Endothelium relaxant factor is a central molecule in vascular homeostasis as a modulator of endothelial tone and reactivity.³ It is produced by NO synthases and exerts pleiotropic positive effects on the cardiovascular system.⁴ Oxidative modification of NO not only leads to reduced bioavailability but also produces the toxic oxidant peroxynitrite, which further aggravates the imbalance of protective and aggressive factors. Because oxidative stress centrally contributes to atherothrombosis, sustained efforts have been undertaken to translate this knowledge into the characterization and identification of biomarkers that enable detection of oxidative stress and allow improved risk stratification by integration into cardiovascular risk stratification models.

	Biomarkers of Oxidative Stress

 
Protagonists of oxidative stress have in common that they are highly active, short-lived agents that almost immediately react with surrounding molecules at the site of formation. However, oxidative species leave a detectable trace of modified oxidative products as is known for oxidized low-density lipoprotein at the site of atherosclerotic lesions. Among a multitude of oxidants that can be measured in vitro and in animal models, only comparatively few biomarkers . . . [Full Text of this Article]

This article has been cited by other articles:

				L. G. Chandrasena, H. Peiris, and H. D. Waikar Biochemical Changes Associated with Reperfusion After Off-Pump and On-Pump Coronary Artery Bypass Graft Surgery Ann. Clin. Lab. Sci., January 1, 2009; 39(4): 372 - 377. [Abstract] [Full Text] [PDF]

				F. Santilli, M. Romano, A. Recchiuti, A. Dragani, A. Falco, G. Lessiani, F. Fioritoni, S. Lattanzio, D. Mattoscio, R. De Cristofaro, et al. Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients Blood, August 15, 2008; 112(4): 1085 - 1090. [Abstract] [Full Text] [PDF]